Bringing embedded intelligence to the point of care to predict drug efficacy and guide personalized treatment choice. This is Precision Oncology 3.0.
A continuous learning model that integrates DNA, RNA, radiology, pathology, EHR data, labs, ctDNA, toxicity and treatment history to compute the optimal therapy at every step.
We built a new operating system for oncology - one that captures every biological signal, unifies all data streams, and utilizes computational intelligence.
As cancer evolves, our system evolves with it, helping oncologists deliver the
best-matched treatment plan, regardless of location or resource constraints.

Our clinical reasoning agents evaluate treatment options, weigh risks and benefits, align with established oncology guidelines, explain therapeutic rationale and automatically re-run analyses whenever new data arrives.
This produces drug response predictions, resistance maps, toxicity alerts, and outcome modeling – not as static reports but as intelligent, operational tools.
gSage CancerAI is our cancer intelligence and care platform – an integrated system built to provide precision oncology workflow in the clinic. It is the first platform designed to provide precision treatment matching at the point of care.
Get concise, reliable answers in seconds for quick reference, with evidence.
Synthesize evidence for complex cases and surface clear rationale, with evidence.
Unite reports, biomarkers, therapies, and notes in one place.
Autogenerate editable briefs with key points and references, with evidence.
Context-aware recommendations reflecting prior lines and biomarkers, with evidence.

gSage CancerAI learns, updates, and evolves its recommendations, just like the oncologists it supports. It builds a digital twin of each cancer patient to simulate drug efficacy. It inspires the care team to stay in continual learning mode to outthink and outpace cancer.
Our GPT-driven platform is embedded in clinical workflow and treatment protocols. We enable real-time decisions around first-line therapy, alternatives for emerging resistance, optimal switch points, next-line strategies after progression, and trial matching based on ongoing biology.
Predicts likely drug efficacy from transcriptomics and patient history to prioritize responders.
Spots early signs of treatment resistance from patterns in test results and past outcomes; prompts timely followup testing.
Checks prior treatments, organ function, and contraindications, to suggest safer alternatives with clinical rationale.
Ranks therapies by guideline concordance, biomarker fit, and lineofcare timing.
Explainable recommendations with confidence scores, trial matching, and shareable board ready briefs.

gSage CancerAI chat explains your reports, labs, and scans in plain language.
Smart question builder creates personalized lists for your provider; save, print, or share securely.
A view that unites reports, biomarkers, treatments, and timelines kept current as new results arrive.
CBT-informed chat and mood tracking with simple exercises and weekly insights to help you cope.
Education and prompts aligned to your data, so you know what to ask, what to watch, and what’s next.
In a world where healthcare is rapidly evolving, Pioneering Health AI is at the forefront of innovation. GeneSilico™ cutting-edge solutions are designed to empower medical professionals, optimize patient care, and transform the way health data is utilized.
From predictive diagnostics to personalized treatment plans, we harness the power of artificial intelligence to make healthcare smarter, faster, and more efficient.
Together, we can reach more patients, improve survival, and transform outcomes. United
as one global team - with technology as our partner - we can advance, learn, and make a
meaningful difference for every person facing cancer.

Matching a patient's tumor multi-Omics bio-profile with most effective drugs for personalized treatment planning and progress tracking and RWE with Causal explainable AI.
Matching a patient's tumor multi-Omics bio-profile with most effective drugs for personalized treatment planning and progress tracking and RWE with Causal explainable AI.
Source, Generate and Share Case Summaries, Drug Matching Analysis, Tumor Board Briefs and Care Triage powered by Multi-Modal Data.
© 2026 GeneSilico. All rights Reserved.